Penumbra enrolls first patient in stroke thrombectomy study

Go back to Penumbra enrolls first patient in stroke thrombectomy study
(NYSE: PEN) Delayed: 317.90 +1.40 (0.44%)
Previous Close $316.50    52 Week High $79.49 
Open $315.70    52 Week Low $40.23 
Day High $317.95    P/E N/A 
Day Low $315.70    EPS $0.00 
Volume 690,634